The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Initial correlative studies from a trial of cetuximab and pembrolizumab in metastatic colorectal cancer (mCRC).
 
Patrick M Boland
Honoraria - Sirtex Medical
Consulting or Advisory Role - Bayer; Ipsen; Ipsen
Research Funding - Advaxis (Inst); Athenex (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Genentech/Roche (Inst); Ipsen (Inst); Merck (Inst)
 
Jason Muhitch
No Relationships to Disclose
 
Scott I Abrams
No Relationships to Disclose
 
Orla Maguire
No Relationships to Disclose
 
Hans Minderman
No Relationships to Disclose
 
David Lawrence Bajor
Consulting or Advisory Role - BridgeBio Pharma; Cardinal Health
Research Funding - Apexigen; Roche/Genentech; Seagen; Tesaro
 
Joel N. Saltzman
Stock and Other Ownership Interests - Array BioPharma; novartis; Roche
Consulting or Advisory Role - IBM
 
Katy Wang
No Relationships to Disclose
 
Alan Hutson
No Relationships to Disclose
 
Sarbajit Mukherjee
Research Funding - Ipsen (Inst)
 
Renuka V. Iyer
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Exelixis; Incyte; Lexicon; Merck; Novartis
Research Funding - Cleveland BioLabs (Inst); Genentech/Roche (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Pawel Kalinski
No Relationships to Disclose
 
Christos Fountzilas
Research Funding - Astellas Pharma (Inst); Incyte (Inst); Kinex (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Rafael Pharmaceuticals (Inst); Seagen (Inst)